Closed-loop (artificial pancreas) systems for automated insulin delivery have been likened
to the holy grail of diabetes management. The first iterations of glucose-responsive insulin …

The artificial pancreas (AP), known as closed-loop control of blood glucose in diabetes, is a
system combining a glucose sensor, a control algorithm, and an insulin infusion device. AP …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

In this two-part Bench to Clinic narrative, recent advances in both the preclinical and clinical
aspects of artificial pancreas (AP) development are described. In the preceding Bench …

Background Recent studies have shown that an artificial-pancreas system can improve
glucose control and reduce nocturnal hypoglycemia. However, it is not known whether such …

Automated closed-loop insulin delivery, also referred to as the'artificial pancreas', has been
an important but elusive goal of diabetes treatment for many decades. Research milestones …

Integrated closed-loop control (CLC), combining continuous glucose monitoring (CGM) with
insulin pump (continuous subcutaneous insulin infusion [CSII]), known as artificial pancreas …

OBJECTIVE To evaluate feasibility, safety, and efficacy of overnight closed-loop insulin
delivery in free-living youth with type 1 diabetes. RESEARCH DESIGN AND METHODS …

We present a robust insulin delivery system that includes automated meal detection and
carbohydrate content estimation using machine learning for meal insulin dosing called …

Despite the continuous efforts devoted to AP development in the last decades, an artificial
pancreas (AP) system is not yet available on the market. One of the major issues involves …